News |  Disclaimer |  Contact |  Sitemap |  Privacy Notice | 
About us  |   Business Development  |   Territories  |   Partners  |  
Shield Therapeutics and Ewopharma sign Feraccru licence agreement for Switzerland
Shield Therapeutics plc (LSE:STX), a speciality pharmaceutical company focused on secondary care, and Ewopharma AG, a pharmaceutical ...

Ewopharma strengthens its oncology business
Eisai Co. Ltd and Ewopharma AG have signed an agreement with which Ewopharma acquires the rights to commercialise several of Eisai's ...

Welcome to Ewopharma.
Your entry to the pharmaceutical markets of Central Eastern Europe.